Górriz, José Luis
Universitat de València · Hospital Clínico Universitario de Valencia
3 papers on CoChatORCID 0000-0002-1134-9051
Most cited papers
- Verified
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., de Torres-Sánchez, A., García-de-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., et al. (2022) · Journal of Clinical Medicine
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 358
- Verified
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
Mann, J. F. E., Rossing, P., Bakris, G., Belmar, N., Bosch-Traberg, H., Busch, R., Charytan, D. M., Hadjadj, S., Gillard, P., Górriz, J. L., et al. (2024) · Nature Medicine
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 200
- Verified
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
Górriz, J. L., Soler, M. J., Navarro-González, J. F., García-Carro, C., Puchades, M. J., D’Marco, L., Martínez Castelao, A., Fernández-Fernández, B., Ortiz, A., Górriz-Zambrano, C., et al. (2020) · Journal of Clinical Medicine
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 144
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free